Jobs / United States / Novartis Pharmaceuticals Corporation

Executive Director, Strategy Prioritization & Governance

Novartis Pharmaceuticals Corporation · 🇺🇸 East Hanover

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles1 certified filing for “Director, Product Strategy Counsel” (Lawyers) in NJ: $157k–$157k, median $157k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Novartis Pharmaceuticals Corporation

75 H-1B filings certified since Oct 2025

The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →

About the role

Job Description Summary This position is based in East Hanover, NJ and will not have the ability to be located remotely. Please note that this role would not provide relocation and only local candidates will be considered. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require up to 20% travel. Reporting into the VP, Head of US Strategy & Execution, this role leads the US Strategy Prioritization & Governance team for the US business and is accountable for building and leading the US Commercial enterprise strategy portfolio prioritization and integrated strategic governance capability, converting US LT priorities into a transparent portfolio of initiatives with clear trade-offs, decision rights, sequencing, capacity signals, risks and outcome tracking. The ED, Strategy Prioritization & Governance Lead is responsible for owning the enterprise strategic initiative intake model, prioritization framework, quarterly portfolio review cadence, US LT decision materials, escalation discipline, and portfolio performance management across non-Reimagining Work strategic initiatives and cross-enterprise priorities. This role will interface closely with senior leadership including US LT and cross-functional leaders while leading a core team of Governance & Portfolio and Planning Leads to build a new capability of integrated intake, prioritization, sequencing, portfolio governance, and strategic outcome tracking across US Commercial Strategy & Execution.   Job Description Key Responsibilities: • Design and operate the US enterprise strategy portfolio governance model, including intake, evaluation, prioritization, sequencing, decision forums, escalation pathways, and outcome tracking.  • Create a consistent prioritization framework balancing strategic value, patient / customer impact, commercial value, capacity, risk, dependencies, feasibility, timing, and enterprise fit.  • Translate US LT imperatives into a governed strategic portfolio and decision-ready recommendations on what to start, stop, accelerate, sequence, or deprioritize.  • Lead quarterly strategic portfolio reviews and monthly executive governance routines; ensure decisions are documented, owned, and followed through.  • Partner with US Business Strategy Lead, Strategic Projects Lead, Transformation pillar, AI & Platform Products pillar, Finance, DDIT and P&O to expose cross-portfolio dependencies and capacity constraints.  • Establish leading and lagging KPIs for strategic initiative delivery and strategic outcomes, not just activity completion.  • Build governance muscle and disciplined portfolio management practices across US Commercial without becoming a bureaucratic PMO.  Essential Requirements: Education  (minimum/desirable):  • Required: Bachelor’s degree in a related field  • Preferred: Advanced degree (Master of Science and/or MBA)   Experience:   • 12+ years of experience in strategy, portfolio management, enterprise governance, commercial strategy, R&D / development portfolio management, transformation, or management consulting.  • Demonstrated experience designing and operating senior-level governance, portfolio review, prioritization, and executive decision processes.  • Proven ability to influence senior stakeholders and force trade-off decisions in a matrixed enterprise environment.  • Strong executive communication, quantitative reasoning, scenario framing, and risk / dependency management skills.  Desirable Requirements: • Pharma portfolio governance, GDD / drug-development portfolio, stage-gate / tollgate, or strategy portfolio experience.  • Experience building a new capability, operating cadence, or control-tower function from scratch.  The salary for this

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-02 Last confirmed: 2026-10-04 How our data works → Report this job

Similar opportunities